On Invalid Date, Artelo Biosciences (NASDAQ: ARTL) reported Q3 2023 earnings per share (EPS) of -$0.83, up 1.22% year over year. Total Artelo Biosciences earnings for the quarter were -$2.45 million. In the same quarter last year, Artelo Biosciences's earnings per share (EPS) was -$0.82.
As of Q4 2023, Artelo Biosciences's earnings has grown year over year. Artelo Biosciences's earnings in the past year totalled -$9.56 million.
What was ARTL's revenue last quarter?
On Invalid Date, Artelo Biosciences (NASDAQ: ARTL) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Artelo Biosciences's revenue was $0.00.
What was ARTL's revenue growth in the past year?
As of Q4 2023, Artelo Biosciences's revenue has grown null year over year. Artelo Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.